The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes.
Arthritis Rheum. 2005 Dec;52(12):3873-9. doi: 10.1002/art.21494.
Arthritis Rheum. 2005.
PMID: 16320335